Procédé de préparation de dérivés actifs d'acide acétique

1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALAIN BENOIT-GUYOD, MADELEINE BROLL, PIERRE LUC BOUCHERLE, LOUIS BOUCHERLE, BERNARD FERRANDES, ANDRE BOUCHERLE, MARCEL TAILLANDIER, GUYOD JEAN-LOUIS, GEORGES TAILLANDIER
Format: Patent
Sprache:fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ALAIN BENOIT-GUYOD
MADELEINE BROLL
PIERRE LUC BOUCHERLE
LOUIS BOUCHERLE
BERNARD FERRANDES
ANDRE BOUCHERLE
MARCEL TAILLANDIER
GUYOD JEAN-LOUIS
GEORGES TAILLANDIER
description 1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_OA5039A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>OA5039A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_OA5039A3</originalsourceid><addsrcrecordid>eNrjZLAPKMpPPrwy5fBKhZRUhYKiwysLEosSSzLz80B8oHBRZtnhlcUKicklmWnFCinqicmZQIlEoJ6SzMLSVB4G1rTEnOJUXijNzSDj5hri7KGbWpAfn1pckJicmpdaEu_vaGpgbOloTEAaAFdPMl0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Procédé de préparation de dérivés actifs d'acide acétique</title><source>esp@cenet</source><creator>ALAIN BENOIT-GUYOD ; MADELEINE BROLL ; PIERRE LUC BOUCHERLE ; LOUIS BOUCHERLE ; BERNARD FERRANDES ; ANDRE BOUCHERLE ; MARCEL TAILLANDIER ; GUYOD JEAN-LOUIS ; GEORGES TAILLANDIER</creator><creatorcontrib>ALAIN BENOIT-GUYOD ; MADELEINE BROLL ; PIERRE LUC BOUCHERLE ; LOUIS BOUCHERLE ; BERNARD FERRANDES ; ANDRE BOUCHERLE ; MARCEL TAILLANDIER ; GUYOD JEAN-LOUIS ; GEORGES TAILLANDIER</creatorcontrib><description>1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.</description><edition>3</edition><language>fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1980</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19801231&amp;DB=EPODOC&amp;CC=OA&amp;NR=5039A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19801231&amp;DB=EPODOC&amp;CC=OA&amp;NR=5039A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALAIN BENOIT-GUYOD</creatorcontrib><creatorcontrib>MADELEINE BROLL</creatorcontrib><creatorcontrib>PIERRE LUC BOUCHERLE</creatorcontrib><creatorcontrib>LOUIS BOUCHERLE</creatorcontrib><creatorcontrib>BERNARD FERRANDES</creatorcontrib><creatorcontrib>ANDRE BOUCHERLE</creatorcontrib><creatorcontrib>MARCEL TAILLANDIER</creatorcontrib><creatorcontrib>GUYOD JEAN-LOUIS</creatorcontrib><creatorcontrib>GEORGES TAILLANDIER</creatorcontrib><title>Procédé de préparation de dérivés actifs d'acide acétique</title><description>1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1980</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAPKMpPPrwy5fBKhZRUhYKiwysLEosSSzLz80B8oHBRZtnhlcUKicklmWnFCinqicmZQIlEoJ6SzMLSVB4G1rTEnOJUXijNzSDj5hri7KGbWpAfn1pckJicmpdaEu_vaGpgbOloTEAaAFdPMl0</recordid><startdate>19801231</startdate><enddate>19801231</enddate><creator>ALAIN BENOIT-GUYOD</creator><creator>MADELEINE BROLL</creator><creator>PIERRE LUC BOUCHERLE</creator><creator>LOUIS BOUCHERLE</creator><creator>BERNARD FERRANDES</creator><creator>ANDRE BOUCHERLE</creator><creator>MARCEL TAILLANDIER</creator><creator>GUYOD JEAN-LOUIS</creator><creator>GEORGES TAILLANDIER</creator><scope>EVB</scope></search><sort><creationdate>19801231</creationdate><title>Procédé de préparation de dérivés actifs d'acide acétique</title><author>ALAIN BENOIT-GUYOD ; MADELEINE BROLL ; PIERRE LUC BOUCHERLE ; LOUIS BOUCHERLE ; BERNARD FERRANDES ; ANDRE BOUCHERLE ; MARCEL TAILLANDIER ; GUYOD JEAN-LOUIS ; GEORGES TAILLANDIER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_OA5039A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>1980</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ALAIN BENOIT-GUYOD</creatorcontrib><creatorcontrib>MADELEINE BROLL</creatorcontrib><creatorcontrib>PIERRE LUC BOUCHERLE</creatorcontrib><creatorcontrib>LOUIS BOUCHERLE</creatorcontrib><creatorcontrib>BERNARD FERRANDES</creatorcontrib><creatorcontrib>ANDRE BOUCHERLE</creatorcontrib><creatorcontrib>MARCEL TAILLANDIER</creatorcontrib><creatorcontrib>GUYOD JEAN-LOUIS</creatorcontrib><creatorcontrib>GEORGES TAILLANDIER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALAIN BENOIT-GUYOD</au><au>MADELEINE BROLL</au><au>PIERRE LUC BOUCHERLE</au><au>LOUIS BOUCHERLE</au><au>BERNARD FERRANDES</au><au>ANDRE BOUCHERLE</au><au>MARCEL TAILLANDIER</au><au>GUYOD JEAN-LOUIS</au><au>GEORGES TAILLANDIER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Procédé de préparation de dérivés actifs d'acide acétique</title><date>1980-12-31</date><risdate>1980</risdate><abstract>1485269 Pharmaceutical compositions containing acetic acid derivatives LABAZ 12 June 1975 [26 June 1974] 28416/74 Heading ASB [Also in Division C2] Pharmaceutical or veterinary compositions, usable in treating non-human subjects with central neurological disorders, comprise as an active ingredient an acetic acid derivative of formula: where R represents where R, and R 2 may be the same or different and each represent an alkyl group with 1-4 carbon atoms, n is an integer from 1-3 inclusive and R 3 and R 4 , which are identical, each represent a straight chain alkyl radical with 1-4 carbon atoms, in association with a carrier or excipient other than Ordinary tap water or a common organic solvent. Preferred active ingredients are 3-n-propyl hexanoic acid; 4-n-propyl-heptanoic acid, 3-n-butyl heptanoic acid, 3-Methyl-butanoic acid, 3-ethyl-pentanoic acid and 5-n-propyl octanoic acid. The composition is preferably in a unit dosage form for rectal or oral administration.</abstract><edition>3</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fre
recordid cdi_epo_espacenet_OA5039A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Procédé de préparation de dérivés actifs d'acide acétique
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T07%3A06%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALAIN%20BENOIT-GUYOD&rft.date=1980-12-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EOA5039A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true